GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » 5-Year Yield-on-Cost %

VRBCF (Virbac) 5-Year Yield-on-Cost % : 0.49 (As of Jul. 21, 2025)


View and export this data going back to . Start your Free Trial

What is Virbac 5-Year Yield-on-Cost %?

Virbac's yield on cost for the quarter that ended in Dec. 2024 was 0.49.


The historical rank and industry rank for Virbac's 5-Year Yield-on-Cost % or its related term are showing as below:

VRBCF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.18   Med: 0.43   Max: 1.49
Current: 0.49


During the past 13 years, Virbac's highest Yield on Cost was 1.49. The lowest was 0.18. And the median was 0.43.


VRBCF's 5-Year Yield-on-Cost % is ranked worse than
86.38% of 514 companies
in the Drug Manufacturers industry
Industry Median: 2.245 vs VRBCF: 0.49

Competitive Comparison of Virbac's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, Virbac's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virbac's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Virbac's 5-Year Yield-on-Cost % falls into.


;
;

Virbac 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Virbac is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Virbac  (OTCPK:VRBCF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Virbac 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Virbac's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac Business Description

Traded in Other Exchanges
Address
13e rue LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.

Virbac Headlines

From GuruFocus

Virbac SA SFAF Meeting Transcript

By GuruFocus Research 03-08-2024

Half Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2018 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2024 Virbac SA Earnings Call Transcript

By GuruFocus Research 09-17-2024

Full Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024